HomeCMMB • NASDAQ
add
Chemomab Therapeutics Ltd - ADR
Previous close
$1.36
Day range
$1.35 - $1.46
Year range
$0.58 - $2.55
Market cap
26.78M USD
Avg Volume
608.08K
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.21M | -16.50% |
Net income | -2.96M | 13.29% |
Net profit margin | — | — |
Earnings per share | -0.01 | 38.46% |
EBITDA | -3.20M | 16.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.27M | -27.89% |
Total assets | 16.96M | -23.42% |
Total liabilities | 3.43M | -33.51% |
Total equity | 13.54M | — |
Shares outstanding | 18.86M | — |
Price to book | 1.89 | — |
Return on assets | -42.43% | — |
Return on capital | -52.64% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.96M | 13.29% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Website
Employees
20
